In humans, a randomized controlled clinical trial evaluated the effect of CoQ10 administration (300 mg/day, P.O for 12 weeks) on the antioxidant system in patients with coronary artery diseases
GHK-Cu rebuilds the structural architecture of the dermis, increasing collagen density and improving the skin's capacity to retain moisture and resist mechanical stress
Immunocal and preservation of glutathione as a novel neuroprotective strategy for degenerative disorders of the nervous system
Advancement in understanding the role of ferroptosis in rheumatoid arthritis
GHK-Cu modulates gene expression across tissue remodeling pathways, including upregulation of collagen types I and III, decorin, and tissue inhibitors of metalloproteinases, while delivering copper to copper-dependent enzymes like lysyl oxidase and superoxide dismutase
Combining GHK-Cu with treatments like microneedling, as directed by a provider, may enhance results